FNC
ABBV icon

First National Corp’s AbbVie ABBV Stock Holding History

First National Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.14M Sell
4,656
-244
-5% -$49.7K 0.22% 76
2025
Q2 		$910K Buy
4,900
+3
+0.1% +$558 0.18% 85
2025
Q1 		$1.03M Sell
4,897
-2,055
-30% -$400K 0.23% 76
2024
Q4 		$1.24M Buy
6,952
+16
+0.2% +$2.94K 0.28% 60
2024
Q3 		$1.37M Sell
6,936
-83
-1% -$15.5K 0.3% 60
2024
Q2 		$1.2M Buy
7,019
+347
+5% +$57.5K 0.29% 70
2024
Q1 		$1.03M Hold
6,672
– – 0.25% 72
2023
Q4 		$1.03M Buy
6,672
+45
+0.7% +$6.56K 0.25% 72
2023
Q3 		$988K Hold
6,627
– – 0.27% 71
2023
Q2 		$893K Buy
6,627
+56
+0.9% +$8.21K 0.21% 78
2023
Q1 		$1.05M Hold
6,571
– – 0.25% 73
2022
Q4 		$1.06M Hold
6,571
– – 0.26% 71
2022
Q3 		$882K Sell
6,571
-22
-0.3% -$3.16K 0.24% 78
2022
Q2 		$1.01M Buy
6,593
+20
+0.3% +$3.06K 0.26% 73
2022
Q1 		$1.07M Sell
6,573
-82
-1% -$11.9K 0.23% 77
2021
Q4 		$901K Sell
6,655
-2
-0% -$236 0.2% 79
2021
Q3 		$718K Buy
6,657
+166
+3% +$19K 0.16% 84
2021
Q2 		$637K Buy
6,491
+178
+3% +$20K 0.22% 75
2021
Q1 		$683K Buy
6,313
+11
+0.2% +$1.18K 0.17% 83
2020
Q4 		$675K Sell
6,302
-189
-3% -$18.2K 0.18% 79
2020
Q3 		$773K Hold
6,491
– – 0.24% 66
2020
Q2 		$637K Sell
6,491
-10
-0.2% -$880 0.22% 75
2020
Q1 		$706K Buy
6,501
+100
+2% +$8.52K 0.46% 49
2019
Q4 		$567K Sell
6,401
-428
-6% -$35.5K 0.21% 80
2019
Q3 		$517K Sell
6,829
-2,253
-25% -$154K 0.21% 83
2019
Q2 		$660K Sell
9,082
-1,315
-13% -$103K 0.27% 68
2019
Q1 		$838K Sell
10,397
-2,485
-19% -$203K 0.35% 54
2018
Q4 		$1.19M Buy
+12,882
New +$1.13M 0.55% 40

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First National Corp's ABBV Position: Q3 2025 in Review

First National Corp reduced its AbbVie (ABBV) stake by 5% in Q3 2025, selling an estimated $49.7K and leaving 4,656 shares worth $1.14M. The position accounts for 0.22% of the portfolio, ranked #76.

First National Corp first reported a position in ABBV in Q4 2018 and has held it in 28 quarters since. The position peaked at $1.37M in Q3 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • First National Corp held 4,656 shares of AbbVie worth $1.14M as of Q3 2025.
  • First National Corp sold 244 AbbVie shares in Q3 2025, an estimated $49.7K.
  • AbbVie made up 0.22% of First National Corp's portfolio in Q3 2025, its #76 holding.
  • First National Corp first reported a position in AbbVie in Q4 2018 and has held it in 28 quarters since.
  • First National Corp's AbbVie position peaked at $1.37M in Q3 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on First National Corp's 13F filing for Q3 2025, filed 28 Oct 2025.